A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in. mice

Mostrar otras versiones (1)

Human respiratory syncytial virus (hRSV) is a major health burden worldwide, causing the majority of hospitalizations in children under two years old due to bronchiolitis and pneumonia. HRSV causes year-to-year outbreaks of disease, which also affects the elderly and immunocompromised adults. Furthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cespedes, Pablo F., Rey-Jurado, Emma, Espinoza, Janyra A., Rivera, Claudia A., Canedo-Marroquin, Gisela, Bueno, Susan M., Kalergis, Alexis M.
Formato: Artículo (Article)
Idioma:Inglés (English)
Publicado: 2025
Materias:
Human respiratory syncytial virus
Pulmonary inflammation
Viral infection
T cells
Th1
Th17
Bacillus Calmette et Guerin
Recombinant vaccine
03 Good Health and Well-being
03 Salud y bienestar
Acceso en línea:https://repositorio.uc.cl/handle/11534/101370

Internet

https://repositorio.uc.cl/handle/11534/101370

Ejemplares similares